Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3234444
Max Phase: Preclinical
Molecular Formula: C29H47N7O7
Molecular Weight: 605.74
Molecule Type: Protein
Associated Items:
ID: ALA3234444
Max Phase: Preclinical
Molecular Formula: C29H47N7O7
Molecular Weight: 605.74
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(N)=O
Standard InChI: InChI=1S/C29H47N7O7/c1-17(2)14-22(29(43)34-21(12-8-9-13-30)27(41)36-24(16-37)25(31)39)35-26(40)18(3)32-28(42)23(33-19(4)38)15-20-10-6-5-7-11-20/h5-7,10-11,17-18,21-24,37H,8-9,12-16,30H2,1-4H3,(H2,31,39)(H,32,42)(H,33,38)(H,34,43)(H,35,40)(H,36,41)/t18-,21-,22-,23-,24-/m0/s1
Standard InChI Key: OXOIMJDXWMEIDK-NHKCCNDQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 605.74 | Molecular Weight (Monoisotopic): 605.3537 | AlogP: -1.65 | #Rotatable Bonds: 19 |
Polar Surface Area: 234.84 | Molecular Species: BASE | HBA: 8 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.77 | CX Basic pKa: 10.19 | CX LogP: -1.98 | CX LogD: -4.58 |
Aromatic Rings: 1 | Heavy Atoms: 43 | QED Weighted: 0.08 | Np Likeness Score: 0.11 |
1. Simhadri C, Daze KD, Douglas SF, Quon TT, Dev A, Gignac MC, Peng F, Heller M, Boulanger MJ, Wulff JE, Hof F.. (2014) Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7)., 57 (7): [PMID:24625057] [10.1021/jm401487x] |
Source(1):